个性化文献订阅>期刊> Cell
 

A polymorphism in CALHM1 influences Ca2+ homeostasis, A beta levels, and Alzheimer's disease risk

  作者 Dreses-Werringloer, U; Lambert, JC; Vingtdeux, V; Zhao, HT; Vais, H; Siebert, A; Jain, A; Koppel, J; Rovelet-Lecrux, A; Hannequin, D; Pasquier, F; Galimberti, D; Scarpini, E; Mann, D; Lendon, C; Campion, D; Amouyel, P; Davies, P; Foskett, JK; Campagne, F; Marambaud, P  
  选自 期刊  Cell;  卷期  2008年133-7;  页码  1149-1161  
  关联知识点  
 

[摘要]Alzheimer's disease (AD) is a genetically heterogeneous disorder characterized by early hippocampal atrophy and cerebral amyloid-beta (A beta) peptide deposition. Using TissueInfo to screen for genes preferentially expressed in the hippocampus and located in AD linkage regions, we identified a gene on 10q24.33 that we call CALHM1. We show that CALHM1 encodes a multipass transmembrane glycoprotein that controls cytosolic Ca2+ concentrations and Ab levels. CALHM1 homomultimerizes, shares strong sequence similarities with the selectivity filter of the NMDA receptor, and generates a large Ca2+ conductance across the plasma membrane. Importantly, we determined that the CALHM1 P86L polymorphism (rs2986017) is significantly associated with AD in independent case-control studies of 3404 participants (allele-specific OR = 1.44, p = 2 x 10(-10)). We further found that the P86L polymorphism increases A beta levels by interfering with CALHM1-mediated Ca2+ permeability. We propose that CALHM1 encodes an essential component of a previously uncharacterized cerebral Ca2+ channel that controls Ab levels and susceptibility to late-onset AD.

 
      被申请数(0)  
 

[全文传递流程]

一般上传文献全文的时限在1个工作日内